The federal judges rejected arguments by two former employees of SmithKline Beecham Co. that pharmaceutical reps cannot be classified as “outside salesmen” — individuals who make sales and obtain orders primarily away from the company’s office. According to the court, pharmaceutical reps fit this definition.
The court decision focused on the definition of ‘sales.’ Federal law prohibits drug companies from selling products directly to the public, meaning individuals must use a prescription from a physician. Pharmaceutical reps visit physicians to persuade them to prescribe company products rather than those sold by competitors.
Read the Arizona Daily Star report on pharmaceutical reps.
Read more on drug manufacturers:
–FDA, Johnson & Johnson Clash Over Rejection of Sedative
–House Hears Arguments Over FDA’s Device Approval Process
–5 Ways Surgery Centers Can Maximize the Benefits of Their Membership With a GPO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.